COMMUNIQUÉS West-GlobeNewswire

Fangzhou Raises HK$150 Million in Share Placement to Accelerate AI-Powered Chronic Care Platform
27/01/2026
HONG KONG, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, has successfully completed a HK$150 million share [...]
Fangzhou Issues Positive Profit Forecast as AI-Driven Chronic Care Model Delivers First Full-Year Profit
27/01/2026
SHANGHAI, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Fangzhou Inc. (“Fangzhou” or the “Company”) (HKEX: 06086), a leading provider of AI-driven Internet healthcare solutions, issued a positive profit forecast for 2025, citing [...]
[Ad hoc announcement pursuant to Art. 53 LR] Roche announces positive Phase II results for its dual GLP-1/GIP receptor agonist CT-388 in people living with obesity
27/01/2026
A once-weekly subcutaneous injection of CT-388 achieved a statistically significant placebo-adjusted weight loss of 22.5% (p < 0.001) at 48 weeks at the highest dose tested (24 mg), without reaching a weight loss [...]
IBA signe un contrat pour l’installation d’un système de protonthérapie Proteus®ONE au MacKay Memorial Hospital, à New Taipei City, Taïwan
27/01/2026
Louvain-la-Neuve, Belgique, le 27 janvier 2026 - IBA (Ion Beam Applications S.A., EURONEXT), leader mondial des technologies d’accélération de particules et principal fournisseur de solutions de protonthérapie pour le [...]
IBA signs contract for a Proteus®ONE proton therapy system to be located at the MacKay Memorial Hospital in New Taipei City, Taiwan
27/01/2026
Louvain-La-Neuve, Belgium, January 27, 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the world’s leading provider of proton therapy solutions for the [...]
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
27/01/2026
Ghent, Belgium, Jan. 27, 2026 (GLOBE NEWSWIRE) -- SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES PRESS RELEASE REGULATED INFORMATION 27 January 2026, 7:00 am CET Ghent, Belgium, 27 January [...]
Pierrick Lefranc nommé Vice-Président Exécutif Opérations Techniques et membre du Comité Exécutif
27/01/2026
PARIS, FRANCE, 27 janvier 2026 - Ipsen (Euronext : IPN ; ADR : IPSEY) annonce aujourd'hui la nomination de Pierrick Lefranc au poste de Vice-Président Exécutif (EVP) et membre du Comité Exécutif (ELT), à compter du 1 er [...]
Pierrick Lefranc appointed as Executive Vice President Technical Operations, member of Executive Leadership Team
27/01/2026
PARIS, FRANCE, 27 January 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that Pierrick Lefranc will be appointed as Executive Vice President (EVP) and member of the Executive Leadership Team (ELT), as of 1 [...]
Bilan semestriel du contrat de liquidité de la société Inventiva conclu avec Kepler Cheuvreux
26/01/2026
Daix (France), New York City (New York, Etats-Unis), le 26 janvier 2026 – Inventiva (Euronext Paris and Nasdaq: IVA) (la "Société"), société biopharmaceutique spécialisée dans le développement de thérapies orales pour [...]
Half-Year Review of Inventiva’s Liquidity Contract with Kepler Cheuvreux
26/01/2026
Daix (France), New York City (New York, United States), January 26, 2026 – Inventiva (Euronext Paris and Nasdaq: IVA) (“ Inventiva ” or the “ Company ”), a clinical-stage biopharmaceutical company focused on the [...]
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
26/01/2026
WATERTOWN, Mass., Jan. 26, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today announced [...]
PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City
26/01/2026
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative solutions in [...]
Beyond Air Schedules Third Fiscal Quarter 2026 Financial Results Conference Call and Webcast
26/01/2026
GARDEN CITY, N.Y., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a commercial stage medical device and biopharmaceutical company focused on harnessing the power of [...]
Outset Medical to Report Fourth Quarter 2025 Financial Results on Wednesday, February 11, 2026
26/01/2026
SAN JOSE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
HNL Lab Medicine Employees Select Local Charities for Annual Donation
26/01/2026
ALLENTOWN, Pa., Jan. 26, 2026 (GLOBE NEWSWIRE) -- HNL Lab Medicine continues its tradition of community giving by empowering employees to nominate nonprofit organizations that hold personal meaning to them. Through this [...]
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
26/01/2026
SAN DIEGO, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that it will report fourth quarter and full year 2025 financial results on Thursday, February 26, 2026 after [...]
Real-World Commercial Experience with Ryoncil® Shows 84% Survival of Children with SR-aGvHD After Completing 28-Days of Treatment
27/01/2026
NEW YORK, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today provided an update on use of Ryoncil ® (remestemcel-L [...]
Hapbee Appoints Marketing Expert Bally Singh to Board of Directors to Spearhead Global Brand Evolution
26/01/2026
Strategic move aligns with record $6.8 trillion global wellness market surge - forecasted to hit $9.8 trillion by 2029 - and drives major company-wide rebrand VANCOUVER, British Columbia, Jan. 26, 2026 (GLOBE NEWSWIRE [...]
Da Vinci 5 Cleared for Cardiac Procedures
26/01/2026
FDA 510(k) clearance expands da Vinci 5 indications to include certain cardiac procedures SUNNYVALE, Calif., Jan. 26, 2026 (GLOBE NEWSWIRE) -- Intuitive (NASDAQ: ISRG), a global technology leader in minimally invasive [...]

Pages